Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization.
Based on an (aminoaryl)benzothiazole quinazoline hit structure for kinase inhibition, a systematic optimization program resulted in a lead structure allowing for inhibitory activities in cellular phosphorylation assays in the low nanomolar range.